FDA cder strategic portfolio ROI framework support
Ended Awarded Last action
- Contract number
- HHSF223201710317W
- Awardee
-
The Mitre Corporation UEI DMHDNDCPWUD1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,999,202
Award facts
- Opportunity
-
- RFPCMS20110021 Solicitation number
- Centers for Medicare & Medicaid Services sponsored Federally Funded Research and Development Center Award Notice · Posted Mar 17, 2011
- Contract value 100% obligated
- $1,999,202.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- West McLean, VA 22102, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $1,999,202 |
About this award
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a cost-plus-fixed-fee delivery order contract to The MITRE Corporation, a nonprofit organization, to provide support for the FDA Center for Drug Evaluation and Research (CDER) Strategic Portfolio Return on Investment (ROI) Framework. The $1,999,202 contract requires MITRE to work with a subcontractor, Grant Thornton LLP's Public Sector Division, to develop a framework for analyzing the ROI of CDER's investments, including conducting stakeholder interviews, reviewing documentation, and evaluating data sources to inform the framework design. The contract does not have a set-aside designation and was awarded on September 19, 2017, with a completion date of September 18, 2018. MITRE leverages its expertise in areas like systems engineering, healthcare IT, and data analytics to support government sponsors across civilian, defense, and intelligence agencies.
Quick answers
Who was awarded contract HHSF223201710317W?
HHSF223201710317W was awarded to The Mitre Corporation by Food and Drug Administration (Department of Health and Human Services) on September 19, 2017.
How much is contract HHSF223201710317W worth?
The government has obligated $1,999,202 on HHSF223201710317W.
Is contract HHSF223201710317W an order under another contract?
Yes. HHSF223201710317W is a delivery order under HHSM500201200008I, an indefinite delivery contract.
Was contract HHSF223201710317W competed?
The extent of competition for HHSF223201710317W was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award